Catalyst Pharmaceuticals, Inc. (CPRX)

Last Closing Price: 24.96 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Catalyst Pharmaceuticals, Inc. (CPRX) had Net Income of $163.89M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$491.73M
Net Income
$163.89M
$68.84M
$422.89M
$296.61M
$195.12M
$21.14M
$216.26M
$216.26M
$163.89M
$163.89M
$163.89M
$163.89M
$195.12M
$232.90M
118.46M
124.94M
$1.38
$1.31
Balance Sheet Financials
$623.61M
$1.35M
$227.80M
$851.41M
$120.68M
--
$3.10M
$123.78M
$727.63M
$570.96M
$727.63M
120.88M
Cash Flow Statement Financials
$239.81M
$-0.56M
$140.66M
$137.64M
$517.55M
$379.92M
$22.25M
--
--
Fundamental Metrics & Ratios
5.17
--
--
--
--
86.00%
39.68%
39.68%
47.36%
43.98%
33.33%
$239.25M
--
--
--
0.58
3.52
7.51
48.60
22.52%
28.70%
19.25%
22.52%
$6.02
$1.91
$1.92